These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 11823575)
1. Food restriction normalizes chylomicron remnant metabolism in murine models of obesity as assessed by a novel stable isotope breath test. Martins IJ; Tran JM; Redgrave TG J Nutr; 2002 Feb; 132(2):176-81. PubMed ID: 11823575 [TBL] [Abstract][Full Text] [Related]
2. Preliminary experience with a new stable isotope breath test for chylomicron remnant metabolism: a study in central obesity. Watts GF; Chan DC; Barrett PH; Martins IJ; Redgrave TG Clin Sci (Lond); 2001 Dec; 101(6):683-90. PubMed ID: 11724657 [TBL] [Abstract][Full Text] [Related]
6. Does pravastatin increase chylomicron remnant catabolism in postmenopausal women with type 2 diabetes mellitus? Ng TW; Watts GF; Stuckey BG; Ching HL; Chan DC; Uchida Y; Sakai N; Yamashita S; Martins IJ; Redgrave TG; Barrett PH Clin Endocrinol (Oxf); 2005 Dec; 63(6):650-6. PubMed ID: 16343099 [TBL] [Abstract][Full Text] [Related]
7. Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression? Mamo JC; Watts GF; Barrett PH; Smith D; James AP; Pal S Am J Physiol Endocrinol Metab; 2001 Sep; 281(3):E626-32. PubMed ID: 11500319 [TBL] [Abstract][Full Text] [Related]
8. Relative roles of mitochondrial and peroxisomal fatty acid oxidation in the metabolism of chylomicron remnants in rats and mice as assessed by a stable-isotope breath test. Martins IJ; Vermeulen R; Redgrave TG Atherosclerosis; 2000 May; 150(1):13-20. PubMed ID: 10781631 [TBL] [Abstract][Full Text] [Related]
9. Chylomicron remnant metabolism studied with a new breath test in postmenopausal women with and without type 2 diabetes mellitus. Dane-Stewart CA; Watts GF; Barrett PH; Stuckey BG; Mamo JC; Martins IJ; Redgrave TG Clin Endocrinol (Oxf); 2003 Apr; 58(4):415-20. PubMed ID: 12641623 [TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity. Chan DC; Watts GF; Mori TA; Barrett PH; Redgrave TG; Beilin LJ Am J Clin Nutr; 2003 Feb; 77(2):300-7. PubMed ID: 12540386 [TBL] [Abstract][Full Text] [Related]
11. Hyperphagia, lower body temperature, and reduced running wheel activity precede development of morbid obesity in New Zealand obese mice. Jürgens HS; Schürmann A; Kluge R; Ortmann S; Klaus S; Joost HG; Tschöp MH Physiol Genomics; 2006 Apr; 25(2):234-41. PubMed ID: 16614459 [TBL] [Abstract][Full Text] [Related]
12. Hyperleptinemia, leptin resistance, and polymorphic leptin receptor in the New Zealand obese mouse. Igel M; Becker W; Herberg L; Joost HG Endocrinology; 1997 Oct; 138(10):4234-9. PubMed ID: 9322935 [TBL] [Abstract][Full Text] [Related]
13. Measurement of expired carbon dioxide to assess the metabolism of remnant lipoproteins. Redgrave TG; Martins IJ; Mortimer B-C J Lipid Res; 1995 Dec; 36(12):2670-5. PubMed ID: 8847493 [TBL] [Abstract][Full Text] [Related]
17. Diurnal rhythm for corticosterone in obese (ob/ob) diabetes (db/db) and gold-thioglucose-induced obesity in mice. Saito M; Bray GA Endocrinology; 1983 Dec; 113(6):2181-5. PubMed ID: 6416815 [TBL] [Abstract][Full Text] [Related]
18. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance. Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693 [TBL] [Abstract][Full Text] [Related]